Genetics and the Endocannabinoid System

Genetics and The Endocannabinoid System: Summary

Len May, CEO and co-founder of EndoDNA, is acclaimed for his leadership in personalized medicine, particularly through his innovative use of DNA-based technology in the field of medical cannabis. May’s company uses patented technology to decode personalized genotypes, leading to customized health solutions. Under his leadership, EndoDNA has developed the world’s largest real-world efficacy database, positioning the company as a leader in precision wellness. With his extensive 25-year career, May has integrated genomics and epigenetics to help individuals achieve optimized health and is actively involved in clinical trials and scientific research.

His educational background includes a master’s in medical cannabis, and his influence spans across academia, industry, and public policy, focusing on safe and effective personalized medicine practices. He shares his personal journey, beginning with managing his ADD symptoms using cannabis, and progressing through various career roles before founding EndoDNA, which provides a platform to guide people in using cannabis based on their unique genetic profiles. This platform is particularly beneficial for those with specific health issues like anxiety, depression, sleep disorders, and inflammation.

The conversation includes how genetic testing can help identify predispositions to certain conditions and tailor cannabis consumption to avoid adverse effects and optimize benefits. In a broader sense, May advocates for an integrative approach to health that includes lifestyle modifications, proper nutrition, and mindfulness practices, rather than solely relying on cannabis or other supplements.